89 results
Page 2 of 5
8-K
EX-10.2
ur80mf3v mua4gunp5qi
14 Dec 20
Entry into a Material Definitive Agreement
6:05am
8-K
EX-99.2
58n7g2
26 May 20
Departure of Directors or Certain Officers
5:14pm
8-K
EX-99.1
6rsagfsr 16u6
5 Feb 20
Innoviva Reports Fourth Quarter 2019 Financial Results
4:31pm
8-K
EX-99.2
nevw09d 6pwd7
23 May 18
Departure of Directors or Certain Officers
12:00am
8-K
EX-99.1
fql7hz q9
10 Apr 17
Innoviva Announces $50 Million Partial Royalty Notes Redemption
12:00am
8-K
EX-99.2
hnl9de4g
1 Dec 14
Anoro® Ellipta® (umeclidinium/vilanterol) to be reimbursed in Australia for Chronic Obstructive Pulmonary Disease
12:00am
8-K
EX-10.4
305gix20st wv1a3qm6
5 Jun 14
Theravance, Inc. and Theravance Biopharma, Inc. Announce
12:00am
8-K
EX-99.2
knb8miug77qscd
5 Jun 14
Theravance, Inc. and Theravance Biopharma, Inc. Announce
12:00am
8-K
EX-10.1
t9u74
5 Jun 14
Theravance, Inc. and Theravance Biopharma, Inc. Announce
12:00am
8-K
EX-10.4
96a3v9c52zetodkcm
21 Apr 14
Theravance Closes Private Placement of $450 Million of 9% Non-Recourse Notes Supporting Strategic Separation Process
12:00am
8-K
EX-10.3
pr5xoif
21 Apr 14
Theravance Closes Private Placement of $450 Million of 9% Non-Recourse Notes Supporting Strategic Separation Process
12:00am
8-K
EX-99.1
0wl427mh uh
9 Jan 14
ANORO™ ELLIPTA™ approved for COPD treatment in Canada
12:00am
8-K
EX-99.1
dzdu9d6dy wt2
18 Dec 13
Other Events
12:00am